Alphabet misses expectations on ad revenue, sending stock lower - Yahoo Finance
| 4109 Stock | TWD 23.80 0.35 1.45% |
Slightly above 62% of Jia Jie's investor base is looking to short. The analysis of current outlook of investing in Jia Jie Biomedical suggests that many traders are alarmed regarding Jia Jie's prospects. Jia Jie's investing sentiment can be driven by a variety of factors including economic data, Jia Jie's earnings reports, geopolitical events, and overall market trends.
Jia Jie stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Jia daily returns and investor perception about the current price of Jia Jie Biomedical as well as its diversification or hedging effects on your existing portfolios.
Jia |
Alphabet misses expectations on ad revenue, sending stock lower Yahoo Finance
Read at news.google.com
 |
Jia Jie Fundamental Analysis
We analyze Jia Jie's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jia Jie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jia Jie based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
Jia Jie is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Jia Jie Biomedical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jia Jie stock to make a market-neutral strategy. Peer analysis of Jia Jie could also be used in its relative valuation, which is a method of valuing Jia Jie by comparing valuation metrics with similar companies.
Peers
Jia Jie Related Equities
| 8028 | Phoenix Silicon | 1.51 | ||||
| 1409 | Shinkong Synthetic | 0.31 | ||||
| 4707 | Pan Asia | 0.35 | ||||
| 1735 | Evermore Chemical | 0.51 | ||||
| 6752 | Galaxy Software | 0.84 | ||||
| 1312A | Grand Pacific | 1.28 | ||||
| 2451 | Transcend Information | 1.29 | ||||
| 2427 | Mercuries Data | 2.29 |
Additional Tools for Jia Stock Analysis
When running Jia Jie's price analysis, check to measure Jia Jie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jia Jie is operating at the current time. Most of Jia Jie's value examination focuses on studying past and present price action to predict the probability of Jia Jie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jia Jie's price. Additionally, you may evaluate how the addition of Jia Jie to your portfolios can decrease your overall portfolio volatility.